Human Immunodeficiency Virus Book



Aka: Lipodystrophy, Lipoatrophy, Peripheral Fat Wasting, Crix Belly, Protease Paunch, Buffalo Humps, Second Chins, Atrophic Facial Cheeks
  1. Pathophysiology
    1. Occurs in some patients never exposed to Antiretroviral
    2. Common adverse effect of Anti-Retroviral Therapy
      1. Occurs in 64% of patients on Protease Inhibitors
      2. Also occurs with nRTI therapy
  2. Signs
    1. Peripheral Fat Wasting
      1. Loss of facial fat (e.g. cheeks with deep dimples)
      2. Loss of subcutaneous fat in the legs
    2. Redistribution of fat centrally
      1. Increased abdominal fat (Protease Paunch)
      2. Gynecomastia
      3. Neck fat pad hypertrophy (Buffalo hump)
        1. Seen also in Cushing's Syndrome
    3. Hyperlipidemia
    4. Insulin Resistance
  3. Complications
    1. Pancreatitis
    2. Metabolic Syndrome equivalent
    3. Pro-thrombotic state with potential increased risks
      1. Cerebrovascular Accident (stroke)
      2. Increased risk of cardiovascular disease
      3. Mortality may be increased
  4. Management
    1. Low Fat Diet
    2. HMG CoA Reductase Inhibitors (Statins)
    3. Fibric Acid derivatives (Gemfibrozil)
    4. Recombinant Growth Hormone
      1. May offer short term benefit in lipohypertrophy
    5. Liposuction with redistribution to areas of fat loss
    6. Polylactic acid and Calcium hydroxylapatite injections
      1. May offer short-term benefit with facial Lipoatrophy
    7. Consider adjusting Antiretroviral regimen
      1. Change Protease Inhibitor (Indinavir to Nelfinavir)
      2. Switch Protease Inhibitor to another Antiretroviral
        1. Nevirapine (Viramune)
        2. Efavirenz (Sustiva)
    8. Hyperinsulinemia
      1. Metformin
      2. Thiazolidinediones (e.g. Rosiglitazone)
        1. Efficacy and safety in Lipodystrophy is unclear
  5. References
    1. Lieu (2001) CMEA Medicine Lecture, San Diego
    2. Hadigan (2001) AIDS Clin Care 13:13-9 [PubMed]
    3. Hadigan (2000) JAMA 284:472-7 [PubMed]
    4. Kuwahara (2002) Am Fam Physician 65(7):1405-6 [PubMed]

Lipodystrophy (C0023787)

Definition (NCI) A congenital or acquired disorder characterized by abnormal loss or redistribution of the adipose tissue in the body.
Definition (CSP) collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat; includes total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy.
Definition (MSH) A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
Concepts Disease or Syndrome (T047)
MSH D008060
ICD9 272.6
ICD10 E88.1
SnomedCT 190790002, 190789006, 71325002
English Lipodystrophies, LIPODYSTROPHY, Lipodystrophy NOS, Lipodystrophy [Disease/Finding], lipodystrophy, lipoatrophy, lipodystrophy (diagnosis), Lipodystrophy NOS (disorder), Dystrophy of fatty tissue, Lipodystrophy (disorder), Lipodystrophy, NOS, Lipodystrophy
French LIPODYSTROPHIE, Lipodystrophies, Lipodystrophie
Portuguese LIPODISTROFIA, Lipodistrofias, Lipodistrofia
Spanish LIPODISTROFIA, lipodistrofia, SAI (trastorno), lipodistrofia, SAI, distrofia del tejido graso, lipodistrofia (trastorno), lipodistrofia, Lipodistrofias, Lipodistrofia
German LIPODYSTROPHIE, Lipodystrophien, Lipodystrophie
Italian Lipodistrofie, Lipodistrofia
Dutch lipodystrofie, lipodystrofieën, Dystrofie, lipo-, Lipodystrofie
Swedish Lipodystrofi
Czech lipodystrofie, Dystrofie tukové tkáně, Lipodystrofie
Finnish Lipodystrofia
Japanese リポジストロフィー, リポジストロフィー
Polish Lipodystrofia, Zanik tkanki podskórnej
Hungarian Lipodystrophiák, Lipodisztrófia
Norwegian Lipodystrofi
Derived from the NIH UMLS (Unified Medical Language System)

Lipoatrophy (C1280433)

Concepts Disease or Syndrome (T047)
SnomedCT 248315005
Italian Lipoatrofia
Japanese 脂肪組織萎縮症, シボウソシキイシュクショウ
Czech Lipoatrofie
English lipoatrophy, Lipoatrophy (disorder), Lipoatrophy
Hungarian Lipodystrophia
Spanish lipoatrofia (trastorno), lipoatrofia, Lipoatrofia
Portuguese Lipoatrofia
Dutch lipo-atrofie
French Lipo-atrophie
German Fettgewebeatrophie
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree